Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

2 235 evidences · page 80 / 90

71 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 71% of HIV-positive persons had viral suppression at year 1 according to fully adjusted estimates.

KenyaVIH/sidaobservé 2013-2017publié 2020Epidemiology (Cambridge, Mass.)PubMeddocument de 8 observations

309 participantsA total of 309 adolescent girls and young women aged 15–24 years living with HIV participated in the study conducted in urban and rural health facilities in and around Kisumu County, western Kenya.

KenyaVIH/sidaobservé January to June 2022publié 2023International journal of environmental research and public healthPubMeddocument de 4 observations

39,7 per_100000HIV/AIDS accounted for the third most frequent cause of deaths in Kenya, with 39.7 deaths per 100,000 population in 2019.

KenyaVIH/sidaobservé 2019publié 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 8 observations

8,5 %8.5% of enrolled AGYW in the HIV-negative cohort tested HIV-positive.

KenyaVIH/sidapublié 2025African journal of AIDS research : AJARPubMeddocument de 8 observations

17 infectionsSeventeen HIV infections occurred over 1247 person-years of follow-up contributed by 670 women in a cohort of HIV-negative female sex workers in Mombasa, Kenya from 2010 to 2017.

KenyaVIH/sidaobservé 2010 to 2017publié 2021AIDS and behavioreurope_pmcdocument de 4 observations

16 %Diarrhoeal diseases were present in 26 (16%) of 162 HIV-attributed infant or child deaths.

Kenyadiarrhoeal diseases · VIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations

48 262 individualsThe number of active children living with HIV on treatment at the end of US Government fiscal year 2021 was 48,262.

KenyaVIH/sidaobservé FY 2021publié 2025The Pediatric infectious disease journalPubMeddocument de 10 observations

15,97 %The gender-based adjusted HIV prevalence among men who inject drugs was 15.97%.

KenyaVIH/sidapublié 2021BMC public healthPubMeddocument de 17 observations

450 daysThe change of logarithm CD4 cell count rises fast in the first 450 days of antiretroviral initiation.

KenyaVIH/sidapublié 2022BMC infectious diseasesPubMeddocument de 5 observations

14,4 %14.4% of HIV-positive adolescents had piped water at home.

KenyaVIH/sidapublié 2020Reproductive healthPubMeddocument de 8 observations

9,7 per_100The risk difference for HIV testing within ≤2 months post-announcement was 9.7 per 100 among female sex workers in the HIV self-testing intervention group compared to standard of care.

KenyaVIH/sidapublié 2022Frontiers in public healthPubMeddocument de 6 observations

45,1 %Among 122 successfully sequenced samples from people with viral nonsuppression in Kenya, 55 (45.1%) had detectable major HIV drug resistance (HIV-DR) mutations.

KenyaVIH/sidapublié 2024AIDS research and human retrovirusesPubMeddocument de 3 observations

26 395 person_yearsIn uMkhanyakude, HIV incidence was estimated over 26,395 person-years.

KenyaVIH/sidapublié 2021PLoS medicinePubMeddocument de 7 observations

0,3 %Among Kenyan adolescents aged 15–19 years in Kisumu, boys were less likely than girls to have used PrEP (0.3% vs. 3.6%).

KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 15 observations

1 267 patientsOf the 1,267 people living with HIV still on legacy antiretroviral regimens at one health facility in Kenya, 459 (36%) were determined to be eligible and prioritized to switch to optimized regimens.

KenyaVIH/sidapublié 2020PloS onePubMeddocument de 4 observations

20 %Of the 658 HIV-1 polymerase sequences analyzed, 131 (20%) were from men who have sex with men (MSM), 58 (9%) from injecting drug users (IDU), 109 (17%) from female sex workers (FSW), and 360 (55%) from heterosexuals (HET).

KenyaVIH/sidaobservé 2005-2019publié 2020Scientific reportsPubMeddocument de 9 observations

15,15 %HIV prevalence was 15.15% among patients with risk-score ≥30.

KenyaVIH/sidaobservé September 2017 to May 2018publié 2021AIDS and behaviorPubMeddocument de 4 observations

45,7 %45.7% of the adolescent girls and young women (AGYW) participants were currently taking pre-exposure prophylaxis (PrEP).

KenyaVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 4 observations

12,6 %HIV-testing rates increased from 12.6% in 2007 to 56.1% in 2012 but decreased slightly to 55.6% in 2018.

KenyaVIH/sidaobservé 2007publié 2022BMC public healthPubMeddocument de 2 observations

9,9 %Over 23,911 follow-up visits in the Mombasa Cohort, the adjusted probability of reporting more than 2 partners decreased from 9.9% to 4.9% after at least 12 cohort visits.

KenyaVIH/sidapublié 2014PloS oneeurope_pmcdocument de 3 observationsDOI 10.1371/journal.pone.0113543

80 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 80% of HIV-positive persons had viral suppression at year 1 according to unadjusted estimates.

KenyaVIH/sidaobservé 2013-2017publié 2020Epidemiology (Cambridge, Mass.)PubMeddocument de 8 observations

48 218 individualsThe number of active children living with HIV on treatment at the end of US Government fiscal year 2020 was 48,218.

KenyaVIH/sidaobservé FY 2020publié 2025The Pediatric infectious disease journalPubMeddocument de 10 observations

14,3 %At baseline, hazardous alcohol use (AUDIT 7-15) was present in 14.3% of HIV-positive female sex workers in Mombasa, Kenya.

KenyaVIH/sidapublié 2020PloS onePubMeddocument de 6 observations

91,7 %In Kenya, point-of-care (POC) early infant diagnosis increased the percentage of HIV-infected infants initiated on treatment from 91.7% to 100%.

KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 13 observations

0,6 %The percentage of HIV infections with PrEP-associated nucleoside reverse transcriptase inhibitor (NRTI) drug resistance was 0.6% in the blood HIV self-testing scenario.

KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 6 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.